[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Thuasne\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":126},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,45,73,99],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100620310","clinical-study-to-assess-the-efficacy-and-pressure-maintenance-of-mobiderm-autofit-versus-bandages-in-the-management-of-breast-cancer-related-lymphedema-bcrl-in-night-time-maintenance-phase-100620310",false,"NCT07355959","Clinical Study to Assess the Efficacy and Pressure Maintenance of MOBIDERM Autofit Versus Bandages in the Management of Breast Cancer Related Lymphedema (BCRL) in Night-time Maintenance Phase.","Cross-over, Randomized, Open Label Study to Assess the Efficacy and Pressure Maintenance of MOBIDERM Autofit Versus Bandages in the Management of Breast Cancer Related Lymphedema (BCRL) in Night-time Maintenance Phase.","MOBISCAN","Inclusion Criteria:\n\n1. Age ≥ 18 years\n2. Unilateral upper limb lymphedema of stage I, II or III according to the criteria defined by the International Society of Lymphology, following breast cancer\n3. Patient in maintenance phase of lymphedema treatment\n4. Affected arm that fits with one of the standard sizes of the Auto- Adjustable MOBIDERM Autofit provided.\n5. Signed informed consent prior to any study-mandated procedure.\n\nExclusion Criteria:\n\n1. Active cellulitis \u002F Infectious dermo-hypodermatitis\n2. Lymphedema associated with active cancer needing acute chemotherapy\n3. Motor and sensitive neurological deficiency \u002F psychiatric or addictive disorders\n4. Patients for whom compression is contraindicated, such as untreated infections, skin irritation, thrombosis: presence of skin lesions on the sleeve placement\n5. Pregnant or breastfeeding patient\n6. Participation to any other clinical study which has an impact on the different endpoints\n7. Vulnerable patient, adults being the object of a legal protective measure or enable to express their consent.","FEMALE","18 Years",{"count":20,"type":21},16,"ESTIMATED","INTERVENTIONAL",[24],"NA","The aim of this cross-over, randomized study is to assess the efficacy and pressure maintenance of MOBIDERM Autofit versus bandages in the management of Breast Cancer Related Lymphedema (BCRL) in night-time maintenance phase.",[27],"Limb Lymphoedema",[29,30,31],"Lymphedema of upper limb","Compression garments","Lymphedema management","NOT_YET_RECRUITING","2026-01-27",{"date":35,"type":36},"2026-01-29","ACTUAL",{"date":38,"type":21},"2026-01-15",{"date":40,"type":21},"2026-07",{"name":42,"class":43},"Thuasne","INDUSTRY",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":53,"minAge":18,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":44},"100602559","a-study-to-evaluate-the-clinical-benefit-and-safety-of-medical-compression-garments-in-the-management-of-patients-with-lipedema-100602559","NCT07125092","A Study to Evaluate the Clinical Benefit and Safety of Medical Compression Garments in the Management of Patients With Lipedema","A Study to Evaluate the Clinical Benefit and Safety of Medical Compression Garments in the Management of Patients With Lipœdema","LIP'EX","Inclusion Criteria:\n\n* Lipedema diagnosed at least in the legs according to the initial Wold criteria modified by Herbst.\n* Average pain in the legs over the last week ≥ 4 points on a 10 points Numerical Rating Scale visual analogue scale.\n* Patient who has given his informed consent freely and signed it prior to any intervention in the study.\n\nExclusion Criteria:\n\n* Patient for whom compression is contraindicated, such as untreated infections, skin irritation or lesions.\n* Lipedema type I: Hips\u002Fbuttocks.\n* Patients who underwent liposuction.\n* Patient with a WHtR higher than 0,58.\n* Patient with active cancer, chemotherapy treatment, chronic inflammatory disease, chronic anti-inflammatory therapy (ex: TNF alpha).\n* Patient with surgery scheduled\u002Fplanned during the study period.\n* Patient with a known allergy to the components used in the devices.\n* Pregnant woman or woman of childbearing age without contraception.\n* Patient currently participating in another clinical investigation that could impact the study endpoints.\n* Patient with psychiatric, psychological, or neurological disorders that are incompatible with the proper follow-up of the clinical investigation.","ALL",{"count":55,"type":21},30,[24],"Lipedema (LI) is a chronic condition, painful disease characterized by a disproportionate increase in adipose tissue and pain in women's legs and sometimes arms. Its prevalence is largely unknown, but lipedema is estimated to affect 0.06% to 11% of the female population. Even though this pathology is increasingly studied and working groups are collaborating to harmonize criteria, a crucial underlying problem of lipedema is the variability in identifying lipedema. Lipedema patients often suffer from obesity, physical disability and psychological impairments, and the effects on quality of life are significant. Almost all women with lipedema are dissatisfied with the disproportionality of their body and the stigma associated with it. In addition to weight gain, pain is one of the major symptoms of this pathology, but also limb heaviness, weakness, or difficulties with walking. Patients also tend to develop easy bruising, although these symptoms are not always present. Treatment of lipedema is aimed at relieving pain, maintaining\u002Fimproving mobility, reducing volume of the limbs, and improving quality of life. It is important to note that compression therapy is one of the cornerstones of this treatment because of its anti-inflammatory effect on adipose tissue",[59],"Lipoedema",[61,62,63,64],"lipoedema","compression","pain","quality of life","2025-08-08",{"date":67,"type":36},"2025-08-15",{"date":69,"type":21},"2025-09-01",{"date":71,"type":21},"2026-10-30",{"name":42,"class":43},{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":81,"targetDuration":4,"studyType":22,"phases":83,"briefSummary":84,"conditions":85,"keywords":87,"overallStatus":89,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},"100536437","auto-adjustable-mobiderm-autofit-armsleeve-in-the-management-of-upper-limb-lymphedema-100536437","NCT06264817","Auto-Adjustable MOBIDERm Autofit Armsleeve in the Management of Upper Limb Lymphedema.","A Multicenter, Single-blinded, Randomized Controlled Study to Assess the Efficacy of Auto-Adjustable MOBIDERL Autofit Armsleeve in the Management of Upper Limb Lymphedema. (LyberT)","LyberT","Inclusion Criteria:\n\n* Unilateral secondary upper limb lymphedema of stage II or III according to the criteria defined by the International Society of Lymphology, following breast cancer\n* Volume difference between affected and healthy arm ≥ 10%\n* Affected arm that fits with one of the 6 standard sizes of the Auto- Adjustable MOBIDERM Autofit armsleeve provided.\n* Signed informed consent prior to any study-mandated procedure.\n\nExclusion Criteria:\n\n* Stage I lymphedema or located in several places.\n* Patients for whom compression is contraindicated.\n* Lymphedema associated with active cancer needing acute chemotherapy or having recurrence or metastasis.\n* Motor and sensitive neurological deficiency \u002F psychiatric or addictive disorders\n* Pregnant or breastfeeding patient\n* Patient intolerant to MOBIDERM Autofit or known allergies to the components used.\n* Participation to any other clinical study which has an impact on the different endpoints\n* Vulnerable patient, adults being the object of a legal protective measure or enable to express their consent.",{"count":82,"type":21},40,[24],"This study aims to assess Auto-Adjustable MOBIDERM® Autofit Armsleeve effect on upper limb volume excess compared to the compression bandages to manage the volume of upper limb lymphedema in patients with breast cancer related lymphedema",[86],"Lymphedema of Upper Limb",[29,30,88],"lymphedema management","RECRUITING","2024-09-20",{"date":92,"type":36},"2024-09-23",{"date":94,"type":36},"2024-03-15",{"date":96,"type":21},"2025-04-15",{"name":42,"class":43},2,{"id":100,"slug":101,"hasResults":11,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":105,"eligibilityCriteria":106,"healthyVolunteers":11,"sex":53,"minAge":18,"maxAge":4,"enrollmentInfo":107,"targetDuration":4,"studyType":22,"phases":109,"briefSummary":110,"conditions":111,"keywords":113,"overallStatus":89,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":119,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":125},"100449355","contribution-of-an-off-the-shelf-carbon-ankle-foot-orthosis-afo-in-the-management-of-walking-functional-impairment-100449355","NCT05131399","Contribution of an Off-the-shelf Carbon Ankle Foot Orthosis (AFO) in the Management of Walking Functional Impairment","Single Case Experimental Design (SCED) Comparing an Off-the-shelf Carbon Ankle Foot Orthosis (SPRYSTEP) Versus an off-the Shelf Standard Plastic Ankle Foot Orthosis in the Treatment of Walking Functional Impairment","DEFISTEP","Inclusion Criteria:\n\n* Patient with a foot levator muscles impairment (single or bilateral drop foot) and \u002F or instability of the back of the foot, associated with a deficit of the triceps\n* Patient with inability to stand on tip-toe on one foot\n* Patient having signed a free and informed consent\n* Patient affiliated or entitled to a social security scheme\n\nExclusion Criteria:\n\n* Patient with fixed varus-equine foot\n* Patient with an unstable skin condition (whether or not treated with additional treatment that may change the footwear)\n* Patient with a a foot levator muscles impairment with a deficiency of the quadriceps and hamstrings (knee involvement)\n* Patient with uncontrolled spasticity\n* Patient for whom foot surgery is planned during the study\n* Patient with one of the contraindications to the use of carbon medical device, indicated in the instructions for use\n* Patient with one of the contraindications to the use of the standard plastic ankle foot orthosis, indicated in the instructions for use\n* Patient with orthopedic comorbidities affecting the musculoskeletal system\n* Pregnant woman\n* Patient with major cognitive impairment incompatible with participation in a clinical trial\n* Patient participating in another clinical investigation conducted to establish the compliance of a MD impacting the evaluation criteria\n* Patient who cannot be followed for 12 weeks\n* Vulnerable patient according to article L1121-6 of the public health code, persons subject to a measure of judicial protection or unable to consent freely",{"count":108,"type":21},20,[24],"The objective of this study is to assess the superiority in achieving personal goals (set by the patient and the medical team) according to the GAS scale (Goal Attainment Scaling) while wearing the carbon medical device Ankle Foot Orthosis (AFO) compared to a standard plastic ankle foot orthosis.",[112],"Neuropathy (Disorder)",[114,115,116,117,118],"orthosis","functional walking impairment","foot drop","rehabilitation","GAS",{"date":92,"type":36},{"date":121,"type":36},"2022-02-28",{"date":123,"type":21},"2024-11",{"name":42,"class":43},8,""]